Understanding Patient Choices in Rectal Cancer Treatment
PATHOS Tradeoffs in Patient Decision Making About Rectal Cancer Treatment: Benefits Compared to Quality Of Life.
This study is trying to understand what treatment options people with operable rectal cancer prefer and how their choices are influenced by their personal circumstances.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 192 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Sir Mortimer B. Davis - Jewish General Hospital Academic / other |
| Locations | 1 site (Montreal, Quebec) |
| Trial ID | NCT04925154 on ClinicalTrials.gov |
What this trial studies
This observational study aims to explore the treatment preferences of patients with operable rectal cancer and the socio-economic factors influencing these choices. It will involve 192 participants, including 178 patients and 14 treating physicians, who will complete two questionnaires assessing their treatment preferences and the trade-offs between benefits and quality of life. Participants will receive an informational brochure detailing various treatment options after the first questionnaire to aid in their decision-making process.
Who should consider this trial
Good fit: Ideal candidates include adults over 18 years old with operable rectal cancer who can provide informed consent and complete online questionnaires.
Not a fit: Patients with metastatic disease, recurrent tumors, or those unable to communicate in English or French may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could enhance patient-centered care by better aligning treatment options with patient preferences and quality of life considerations.
How similar studies have performed: While there have been studies on treatment preferences in cancer care, this specific approach focusing on socio-economic factors and quality of life trade-offs is relatively novel.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: Group A * New rectal cancer patient * Operable patients * Capable adults older than 18 years of age * Capacity to sign a consent form * Capacity to answer questionnaires on an online platform Group B * Treating physician specialists * Capacity to sign a consent form * Capacity to answer questionnaires on an online platform Exclusion Criteria: Group A: * Patient unable to sign a consent form * Patients with metastasis * Recurrent tumours * Inability to answer questionnaires on an online platform * Inability to communicate in french or english Group B: * Participant unable to sign a consent form * Inability to answer questionnaires on an online platform
Where this trial is running
Montreal, Quebec
- Jewish General Hospital — Montreal, Quebec, Canada (Recruiting)
Study contacts
- Principal investigator: Té Vuong — Lady Davis Institute - JGH
- Study coordinator: Emma Starr, BHSc
- Email: emma.starr.ccomtl@ssss.gouv.qc.ca
- Phone: 514-340-8222
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.